The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium. [electronic resource]
Producer: 20180626Description: 724-732 p. digitalISSN:- 1522-726X
- Aged
- Anticoagulants -- adverse effects
- Antithrombins -- adverse effects
- Blue Cross Blue Shield Insurance Plans
- Comparative Effectiveness Research
- Coronary Artery Disease -- complications
- Female
- Hemorrhage -- chemically induced
- Heparin -- adverse effects
- Hirudins -- adverse effects
- Humans
- Logistic Models
- Male
- Michigan
- Middle Aged
- Odds Ratio
- Peptide Fragments -- adverse effects
- Percutaneous Coronary Intervention -- adverse effects
- Propensity Score
- Recombinant Proteins -- adverse effects
- Registries
- Renal Dialysis -- adverse effects
- Renal Insufficiency, Chronic -- complications
- Retrospective Studies
- Risk Factors
- Stents
- Thrombosis -- diagnosis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.